NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

NCT06752603

CompletedPhase 2

Sponsor: Ono Pharmaceutical Co., Ltd.

Conditions: Hunner Type Interstitial Cystitis

Interventions: ONO-1110, Placebo

Countries: Japan

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Japanese (both sexes)
* Age (at the time of informed consent): 18 years and older
* Outpatient
* Patients who are considered capable of understanding the study procedures and completing the pain diary, bladder diary, and questionnaires appropriately by the investigator (sub-investigator）
* Patients given a diagnosis of HIC by cystoscopy
* Patients with chronic pelvic pain involving the bladder and lower urinary tract symptoms such as increased micturition and pollakiuria

Exclusion Criteria:

* Patients with a history and presence of chemical cystitis
* Patients with a history of bladder augmentation or radical cystectomy
* Patients with pain other than HIC that may affect assessments in this study
* Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
* Patients receiving medications for psychiatric disease

Locations (20)

Nagoya, Aichi-ken, Japan
Fukuoka, Fukuoka, Japan
Fukushima, Fukushima, Japan
Gifu, Gifu, Japan
Takasaki, Gunma, Japan
Kagoshima, Kagoshima-ken, Japan
Kawasaki, Kanagawa, Japan
Kyoto, Kyoto, Japan
Kyoto, Kyoto, Japan
Sendai, Miyagi, Japan
Matsumoto, Nagano, Japan
Beppu, Oita Prefecture, Japan
Okayama, Okayama-ken, Japan
Saga, Saga-ken, Japan
Minato-Ku, Tokyo, Japan
Mitaka, Tokyo, Japan
Tokyo, Tokyo, Japan
Uozu, Toyama, Japan
Chūō, Yamanashi, Japan
Nagasaki, Japan